LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test
- Written by PR Newswire
Now Available in Europe, parts of the Middle East, Asia, Latin America, and Africa
- Early customers include GP offices and other community-based healthcare settings
- Latest figures, released as part of World Diabetes Day, reveal that 1 in 10 adults are now living with diabetes and nearly half are undiagnosed1
- The LumiraDx HbA1c test is designed...
Read more: LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test














